IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i21p14381-d961856.html
   My bibliography  Save this article

An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study

Author

Listed:
  • Najwa Abdulwahed Al Bastaki

    (Department of Public Health Protection, Dubai Health Authority, Dubai P.O. Box 4545, United Arab Emirates)

  • Mohamud Sheek-Hussein

    (Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates
    School of Public Health, Loma Linda University, Loma Linda, CA 92354, USA)

  • Ankita Shukla

    (Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates)

  • Najlaa Al-Bluwi

    (Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates)

  • Basema Saddik

    (Sharjah Institute for Medical and Health Sciences Research, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates
    Department of Family and Community Medicine and Behavioural Sciences, College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates)

Abstract

The aim of this study was to determine the prevalence of non-communicable diseases and their correlation with COVID-19 disease severity among patients infected in Dubai. Clinical and demographic data were extracted from hospital records of 34,687 COVID-19 patients who visited or were admitted into Dubai hospitals between 28 January 2020 and 30 September 2020. Prevalence of co-morbidities in COVID-19 patients were assessed. The main risk factors associated with COVID-19 disease severity were also identified using three regression models. All co-morbidities were significantly associated with COVID-19 severity in the bivariate analysis ( p -value ≤ 0.05) except for vitamin-D deficiency and chronic lower respiratory diseases. Patients with ischemic heart diseases (AOR: 2.08; 95% CI: 1.37, 3.15), pulmonary and other heart diseases (AOR: 2.13; 95% CI: 1.36, 3.32) and chronic kidney diseases (AOR: 1.81; 95% CI: 1.01, 3.25) had higher odds of severe COVID-19 symptoms. Suffering from multiple co-morbidities increased the odds of developing severe COVID-19 symptoms substantially in comparison to having only one co-morbidity i.e., (AOR: 1.52; 95% CI 1.76–2.60) to (AOR: 2.33; 95% CI: 1.37, 3.97). Identifying these risk factors could assist in the early recognition of high-risk populations and ensure the most appropriate preventive measures and required medical management during the pandemic.

Suggested Citation

  • Najwa Abdulwahed Al Bastaki & Mohamud Sheek-Hussein & Ankita Shukla & Najlaa Al-Bluwi & Basema Saddik, 2022. "An Evaluation of Non-Communicable Diseases and Risk Factors Associated with COVID-19 Disease Severity in Dubai, United Arab Emirates: An Observational Retrospective Study," IJERPH, MDPI, vol. 19(21), pages 1-14, November.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:21:p:14381-:d:961856
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/21/14381/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/21/14381/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Nathan R Hill & Samuel T Fatoba & Jason L Oke & Jennifer A Hirst & Christopher A O’Callaghan & Daniel S Lasserson & F D Richard Hobbs, 2016. "Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-18, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gabriela Ortiz, 2023. "New meta-analysis (MA) features in Stata 18: MA for prevalence and multilevel MA," Canadian Stata Conference 2023 06, Stata Users Group.
    2. William P Martin & Neil G Docherty & Carel W Le Roux, 2017. "Bariatric Surgery for the Treatment of Diabetic Kidney Disease," Current Research in Diabetes & Obesity Journal, Juniper Publishers Inc., vol. 3(5), pages 1-4, August.
    3. V Boima & K Agyabeng & V Ganu & D Dey & E Yorke & M B Amissah-Arthur & A A Wilson & A E Yawson & C C Mate-Kole & J Nonvignon, 2020. "Willingness to pay for kidney transplantation among chronic kidney disease patients in Ghana," PLOS ONE, Public Library of Science, vol. 15(12), pages 1-15, December.
    4. Christian T. Litchepah & Issidor. Noumba & Mohammadou. Nourou, 2022. "Does reducing violence against women improve children’s health? The case of Cameroon," International Journal of Research and Innovation in Social Science, International Journal of Research and Innovation in Social Science (IJRISS), vol. 6(6), pages 187-194, June.
    5. Qingqing Cai & Louise H Dekker & Stephan J L Bakker & Martin H de Borst & Gerjan Navis, 2019. "Intraregional differences in renal function in the Northern Netherlands: The Lifelines Cohort Study," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-15, October.
    6. Gabriela Ortíz, "undated". "New meta-analysis (MA) features in Stata 18: MA for prevalence and multilevel MA," Spanish Stata Conference 2023 03, Stata Users Group.
    7. John Pastor Ansah & Shawn Tan Yi Wei & Tessa Lui Shi Min, 2020. "An evaluation of the impact of aggressive diabetes and hypertension management on chronic kidney diseases at the population level: a simulation analysis," System Dynamics Review, System Dynamics Society, vol. 36(4), pages 497-522, October.
    8. Hayfa Almutary & Nahla Tayyib, 2021. "Translation, Adaptation, and Validation of Chronic Kidney Disease Self-Management and Knowledge Instruments for People at Pre-Dialysis Stage in the Arab World," Clinical Nursing Research, , vol. 30(8), pages 1231-1240, November.
    9. Don O’Mahony & Sikhumbuzo A. Mabunda & Mbulelo Mntonintshi & Joshua Iruedo & Ramprakash Kaswa & Ernesto Blanco-Blanco & Basil Ogunsanwo & Kakia Anne Faith Namugenyi & Sandeep Vasaikar & Parimalaranie , 2023. "Causes of Moderate and Severe Anaemia in a High-HIV and TB-Prevalent Adult Population in the Eastern Cape Province, South Africa," IJERPH, MDPI, vol. 20(4), pages 1-17, February.
    10. Nisith Kumar Mohanty & Krushna Chandra Sahoo & Sanghamitra Pati & Asish K. Sahu & Reena Mohanty, 2020. "Prevalence of Chronic Kidney Disease in Cuttack District of Odisha, India," IJERPH, MDPI, vol. 17(2), pages 1-8, January.
    11. William P Martin & Neil G Docherty & Carel W Le Roux, 2017. "Bariatric Surgery for the Treatment of Diabetic Kidney Disease," Current Research in Diabetes & Obesity Journal, Juniper Publishers Inc., vol. 3(5), pages 90-93, August.
    12. Gabriela Maria Reis Goncalves & Everton Nunes da Silva, 2018. "Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-15, October.
    13. Jing Zeng & Miao Liu & Lei Wu & Jianhua Wang & Shanshan Yang & Yiyan Wang & Yao Yao & Bin Jiang & Yao He, 2016. "The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population," IJERPH, MDPI, vol. 13(12), pages 1-10, December.
    14. Pongpan Suriyong & Chidchanok Ruengorn & Chairat Shayakul & Puree Anantachoti & Penkarn Kanjanarat, 2022. "Prevalence of chronic kidney disease stages 3–5 in low- and middle-income countries in Asia: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-18, February.
    15. Kamolpat Chaiyakittisopon & Oraluck Pattanaprateep & Narisa Ruenroengbun & Tunlanut Sapankaew & Atiporn Ingsathit & Gareth J. Mckay & John Attia & Ammarin Thakkinstian, 2021. "Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 571-584, June.
    16. Kuan Y. Chang & I-Wen Wu & Bo-Ruei Huang & Jih-Gau Juang & Jia-Chyi Wu & Su-Wei Chang & Chung Cheng Chang, 2018. "Associations between Water Quality Measures and Chronic Kidney Disease Prevalence in Taiwan," IJERPH, MDPI, vol. 15(12), pages 1-15, December.
    17. Pim P Valentijn & Fernando Pereira & Christina W Sterner & Hubertus J M Vrijhoef & Dirk Ruwaard & Jörgen Hegbrant & Giovanni F M Strippoli, 2019. "Validation of the Rainbow Model of Integrated Care Measurement Tools (RMIC-MTs) in renal care for patient and care providers," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-21, September.
    18. John Pastor Ansah & Keith Low Sheng Hng & Salman Ahmad & Cheryl Goh, 2021. "Evaluating the impact of upstream and downstream interventions on chronic kidney disease and dialysis care: a simulation analysis," System Dynamics Review, System Dynamics Society, vol. 37(1), pages 32-58, January.
    19. Alexandra-Elena Marin & Rosa Redolat & José-Antonio Gil-Gómez & Patricia Mesa-Gresa, 2023. "Addressing Cognitive Function and Psychological Well-Being in Chronic Kidney Disease: A Systematic Review on the Use of Technology-Based Interventions," IJERPH, MDPI, vol. 20(4), pages 1-21, February.
    20. Po-Jen Hsiao & Chih-Chien Chiu & Dung-Jang Tsai & Pi-Shao Ko & Ying-Kai Chen & Hao Cheng & Wen Su & Kuo-Cheng Lu & Sui-Lung Su, 2021. "Association between nitric oxide synthase T-786C genetic polymorphism and chronic kidney disease: Meta-analysis incorporating trial sequential analysis," PLOS ONE, Public Library of Science, vol. 16(10), pages 1-16, October.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:21:p:14381-:d:961856. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.